These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

691 related items for PubMed ID: 30629804

  • 21. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.
    Qi X, He C, Guo W, Yin Z, Wang J, Wang Z, Niu J, Bai M, Yang Z, Fan D, Han G.
    Liver Int; 2016 May; 36(5):667-76. PubMed ID: 26235541
    [Abstract] [Full Text] [Related]

  • 22. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
    Sauerbruch T, Mengel M, Dollinger M, Zipprich A, Rössle M, Panther E, Wiest R, Caca K, Hoffmeister A, Lutz H, Schoo R, Lorenzen H, Trebicka J, Appenrodt B, Schepke M, Fimmers R, German Study Group for Prophylaxis of Variceal Rebleeding.
    Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386
    [Abstract] [Full Text] [Related]

  • 23. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy in the elective treatment of recurrent variceal bleeding.
    Popovic P, Stabuc B, Skok P, Surlan M.
    J Int Med Res; 2010 Sep; 38(3):1121-33. PubMed ID: 20819451
    [Abstract] [Full Text] [Related]

  • 24. Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial.
    Gülberg V, Schepke M, Geigenberger G, Holl J, Brensing KA, Waggershauser T, Reiser M, Schild HH, Sauerbruch T, Gerbes AL.
    Scand J Gastroenterol; 2002 Mar; 37(3):338-43. PubMed ID: 11916197
    [Abstract] [Full Text] [Related]

  • 25. Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature.
    Strunk H, Marinova M.
    Rofo; 2018 Aug; 190(8):701-711. PubMed ID: 30045395
    [Abstract] [Full Text] [Related]

  • 26. Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization.
    Chen S, Li X, Wei B, Tong H, Zhang MG, Huang ZY, Cao JW, Tang CW.
    Radiology; 2013 Sep; 268(3):900-6. PubMed ID: 23657891
    [Abstract] [Full Text] [Related]

  • 27. Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker.
    Chen Y, Ma X, Zhang X, Luo J, An L, Zhang Y, Chang X, Dong Z, Zhang W, Kong H, Zhao J, Ding H, Liu F, Yang Y.
    Hepatol Int; 2022 Dec; 16(6):1379-1389. PubMed ID: 36255564
    [Abstract] [Full Text] [Related]

  • 28. Clinical results of the transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of variceal bleeding.
    Han SW, Joo YE, Kim HS, Choi SK, Rew JS, Kim JK, Kim SJ.
    Korean J Intern Med; 2000 Dec; 15(3):179-86. PubMed ID: 11242805
    [Abstract] [Full Text] [Related]

  • 29. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
    Membreno F, Baez AL, Pandula R, Walser E, Lau DT.
    J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
    [Abstract] [Full Text] [Related]

  • 30. [A comparison of efficacies between transjugular intrahepatic portosystemic shunt versus portoazygos devascularization in the treatment of portal hypertension with variceal bleeding].
    Xu XB, Chu JG, Huang H, Zhang HY, Zhang HY, Liu CL, Xiao M, Zhang H, Feng ZQ, Zhao G.
    Zhonghua Yi Xue Za Zhi; 2012 Sep 25; 92(36):2542-5. PubMed ID: 23158794
    [Abstract] [Full Text] [Related]

  • 31. Comparison of transjugular intrahepatic portosystemic with endoscopic treatment plus anticoagulation for esophageal variceal bleeding and portal vein thrombosis in liver cirrhosis.
    Wu W, Zhang H, Zeng Z, Wang X, Kong D.
    Scand J Gastroenterol; 2022 Dec 25; 57(12):1494-1502. PubMed ID: 35802771
    [Abstract] [Full Text] [Related]

  • 32. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft.
    Wan YM, Li YH, Xu Y, Wu HM, Li YC, Wu XN, Yang JH.
    Acad Radiol; 2018 Jul 25; 25(7):925-934. PubMed ID: 29373208
    [Abstract] [Full Text] [Related]

  • 33. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L.
    J Clin Gastroenterol; 2007 Jul 25; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [Abstract] [Full Text] [Related]

  • 34. [Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in liver cirrhosis: intended population and timing].
    Lyu Y, Han GH, Fan DM.
    Zhonghua Gan Zang Bing Za Zhi; 2017 Jun 20; 25(6):402-407. PubMed ID: 28763854
    [Abstract] [Full Text] [Related]

  • 35. Early use of TIPS in patients with cirrhosis and variceal bleeding.
    García-Pagán JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, Abraldes JG, Nevens F, Vinel JP, Mössner J, Bosch J, Early TIPS (Transjugular Intrahepatic Portosystemic Shunt) Cooperative Study Group.
    N Engl J Med; 2010 Jun 24; 362(25):2370-9. PubMed ID: 20573925
    [Abstract] [Full Text] [Related]

  • 36. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β-blocker for prevention of variceal rebleeding.
    Holster IL, Tjwa ET, Moelker A, Wils A, Hansen BE, Vermeijden JR, Scholten P, van Hoek B, Nicolai JJ, Kuipers EJ, Pattynama PM, van Buuren HR.
    Hepatology; 2016 Feb 24; 63(2):581-9. PubMed ID: 26517576
    [Abstract] [Full Text] [Related]

  • 37. Randomized trials of endoscopic therapy and transjugular intrahepatic portosystemic shunt versus portacaval shunt for emergency and elective treatment of bleeding gastric varices in cirrhosis.
    Orloff MJ, Hye RJ, Wheeler HO, Isenberg JI, Haynes KS, Vaida F, Girard B, Orloff KJ.
    Surgery; 2015 Jun 24; 157(6):1028-45. PubMed ID: 25957003
    [Abstract] [Full Text] [Related]

  • 38. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.
    Jalan R, Elton RA, Redhead DN, Finlayson ND, Hayes PC.
    J Hepatol; 1995 Aug 24; 23(2):123-8. PubMed ID: 7499782
    [Abstract] [Full Text] [Related]

  • 39. Clinical Efficacy of Transjugular Intrahepatic Portosystemic Shunt Created with Expanded Polytetrafluoroethylene-Covered Stent-Grafts: 8-mm Versus 10-mm.
    Luo X, Wang X, Zhu Y, Xi X, Zhao Y, Yang J, Li X, Yang L.
    Cardiovasc Intervent Radiol; 2019 May 24; 42(5):737-743. PubMed ID: 30643936
    [Abstract] [Full Text] [Related]

  • 40. Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts.
    Kochar N, Tripathi D, McAvoy NC, Ireland H, Redhead DN, Hayes PC.
    Aliment Pharmacol Ther; 2008 Aug 01; 28(3):294-303. PubMed ID: 19086235
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.